Trial Profile
A Dose-Ranging and Dose Frequency Study Evaluating the Safety and Efficacy of LIPO-102 for the Reduction of Abdominal Subcutaneous Adipose Tissue
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Apr 2015
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Subcutaneous fat disorders
- Focus Adverse reactions
- Sponsors Neothetics
- 08 Aug 2014 New trial record